[1]ChemicalCommunications,2018,vol.54,p.4521-4524
[1]CurrentPatentAssignee:UNIVERSITEDERENNES1;NATIONALINSTITUTEOFAPPLIEDSCIENCES;NATIONALINSTITUTEOFHEALTHANDMEDICALRESEARCH;UNIVNANGUIABROGOUA;UNIVERSITEDEBRETAGNEOCCIDENTALE;CENTRENATIONALDELARECHERCHESCIENTIFIQUE;CHRUDEBREST;ECOLENATIONALESUPERIEUREDECHIMIEDERENNES-WO2021/233994,2021,A1Locationinpatent:Page/Pagecolumn48
[2]CurrentPatentAssignee:UNIVERSITEDERENNES1;NATIONALINSTITUTEOFAPPLIEDSCIENCES;NATIONALINSTITUTEOFHEALTHANDMEDICALRESEARCH;UNIVNANGUIABROGOUA;UNIVERSITEDEBRETAGNEOCCIDENTALE;CENTRENATIONALDELARECHERCHESCIENTIFIQUE;CHRUDEBREST;ECOLENATIONALESUPERIEUREDECHIMIEDERENNES-WO2021/233994,2021,A1Locationinpatent:Page/Pagecolumn48
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101